{"abstract": "Nobody really knows if Valeant Pharmaceuticals is doing anything that makes money, or is just engaged in prestidigitation that never gets anywhere, writes Jesse Eisinger in The Trade.", "web_url": "https://dealbook.nytimes.com/2014/06/04/in-valeants-bid-for-allergan-an-opaque-business-model-is-revealed/", "snippet": "Nobody really knows if Valeant Pharmaceuticals is doing anything that makes money, or is just engaged in prestidigitation that never gets anywhere, writes Jesse Eisinger in The Trade.", "lead_paragraph": "On Wall Street, financial engineering masquerades as vision. When it works, you get to be called the Oracle of somewhere or other. If it works for only a short period, you can still get rich. What a country.", "print_section": "B", "print_page": "8", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/05/business/Eisinger/Eisinger-articleLarge.jpg", "height": 434, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/06/05/business/Eisinger/Eisinger-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 434}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/05/business/Eisinger/Eisinger-jumbo.jpg", "height": 741, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/05/business/Eisinger/Eisinger-superJumbo.jpg", "height": 1481, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/05/business/Eisinger/Eisinger-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/06/05/business/Eisinger/Eisinger-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/05/business/Eisinger/Eisinger-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "In Valeant\u2019s Bid for Allergan, an Opaque Business Model Is Revealed", "kicker": "DealBook", "content_kicker": null, "print_headline": "In Valeant\u2019s Bid for Allergan, an Opaque Business Model", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Company Reports", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Ackman, William A", "rank": 3, "major": "N"}, {"name": "persons", "value": "Pearson, Michael", "rank": 4, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 6, "major": "N"}], "pub_date": "2014-06-04T16:00:03+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Jesse Eisinger", "person": [{"firstname": "Jesse", "middlename": null, "lastname": "Eisinger", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/2225dc61-8943-5b0e-b2b7-cfe1d3efaeca", "word_count": 1079, "uri": "nyt://article/2225dc61-8943-5b0e-b2b7-cfe1d3efaeca"}